Abbott is confident its new Navitor transcatheter aortic valve replacement (TAVR) will help it rapidly take share away from TAVR competitors Medtronic and Edwards Lifesciences in the next few years.
Navitor features the NaviSeal fabric cuff to reduce paravalvular leak and large curved aortic “cells” to reduce the risk of injury to the native valve structures while providing optimal radial...